DEXCOM, INC. Research and Development Expense
DEXCOM, INC. (DXCM) reported Research and Development Expense of $153.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-30
- DEXCOM, INC. research and development expense for the quarter ending 2026-06-30 was $153.00M, a 3.24% increase year-over-year.
- DEXCOM, INC. research and development expense for the quarter ending 2026-03-31 was $145.30M, a 0.07% increase year-over-year.
- DEXCOM, INC. research and development expense for the quarter ending 2025-12-31 was $148.20M, a 6.24% increase year-over-year.
- DEXCOM, INC. research and development expense for the quarter ending 2025-09-30 was $157.50M, a 16.32% increase year-over-year.
- DEXCOM, INC. research and development expense for fiscal 2025 was $599.10M, a 8.45% increase from fiscal 2024.
- DEXCOM, INC. research and development expense for fiscal 2024 was $552.40M, a 9.21% increase from fiscal 2023.
- DEXCOM, INC. research and development expense for fiscal 2023 was $505.80M, a 4.46% increase from fiscal 2022.
- DEXCOM, INC. research and development expense for fiscal 2022 was $484.20M, a 6.36% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $153.00M 10-Q · filed 2026-07-30 | $298.30M 10-Q · filed 2026-07-30 | $446.50M derived: sum of 3 quarters · filed 2026-07-30 | $604.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $145.30M 10-Q · filed 2026-04-30 | $293.50M derived: sum of 2 quarters · filed 2026-04-30 | $451.00M derived: sum of 3 quarters · filed 2026-04-30 | $599.20M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $148.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $305.70M derived: sum of 2 quarters · filed 2026-02-12 | $453.90M derived: sum of 3 quarters · filed 2026-07-30 | $599.10M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $157.50M 10-Q · filed 2025-10-30 | $305.70M derived: sum of 2 quarters · filed 2026-07-30 | $450.90M 10-Q · filed 2025-10-30 | $590.40M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $148.20M 10-Q · filed 2026-07-30 | $293.40M 10-Q · filed 2026-07-30 | $432.90M derived: sum of 3 quarters · filed 2026-07-30 | $568.30M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $145.20M 10-Q · filed 2026-04-30 | $284.70M derived: sum of 2 quarters · filed 2026-04-30 | $420.10M derived: sum of 3 quarters · filed 2026-04-30 | $556.10M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $139.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $274.90M derived: sum of 2 quarters · filed 2026-02-12 | $410.90M derived: sum of 3 quarters · filed 2026-02-12 | $552.40M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $135.40M 10-Q · filed 2025-10-30 | $271.40M derived: sum of 2 quarters · filed 2025-10-30 | $412.90M 10-Q · filed 2025-10-30 | $549.00M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $136.00M 10-Q · filed 2025-07-30 | $277.50M 10-Q · filed 2025-07-30 | $413.60M derived: sum of 3 quarters · filed 2026-02-12 | $545.00M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | $141.50M 10-Q · filed 2025-05-01 | $277.60M derived: sum of 2 quarters · filed 2026-02-12 | $409.00M derived: sum of 3 quarters · filed 2026-02-12 | $528.30M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $136.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $267.50M derived: sum of 2 quarters · filed 2026-02-12 | $386.80M derived: sum of 3 quarters · filed 2026-02-12 | $505.80M 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | $131.40M 10-Q · filed 2024-10-24 | $250.70M derived: sum of 2 quarters · filed 2024-10-24 | $369.70M 10-Q · filed 2024-10-24 | $486.00M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $119.30M 10-Q · filed 2024-07-25 | $238.30M 10-Q · filed 2024-07-25 | $354.60M derived: sum of 3 quarters · filed 2025-02-18 | $464.90M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $119.00M 10-Q · filed 2024-04-25 | $235.30M derived: sum of 2 quarters · filed 2025-02-18 | $345.60M derived: sum of 3 quarters · filed 2025-02-18 | $467.30M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $116.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $226.60M derived: sum of 2 quarters · filed 2025-02-18 | $348.30M derived: sum of 3 quarters · filed 2025-02-18 | $484.20M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | $110.30M 10-Q · filed 2023-10-26 | $232.00M derived: sum of 2 quarters · filed 2023-10-26 | $367.90M 10-Q · filed 2023-10-26 | $517.70M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2022-06-30 | $121.70M 10-Q · filed 2023-07-27 | $257.60M 10-Q · filed 2023-07-27 | $407.40M derived: sum of 3 quarters · filed 2024-02-08 | $536.20M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2022-03-31 | $135.90M 10-Q · filed 2023-04-27 | $285.70M derived: sum of 2 quarters · filed 2024-02-08 | $414.50M derived: sum of 3 quarters · filed 2024-02-08 | $543.60M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2021-12-31 | $149.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $278.60M derived: sum of 2 quarters · filed 2024-02-08 | $407.70M derived: sum of 3 quarters · filed 2024-02-08 | $517.10M 10-K · filed 2024-02-08 | ||||
| 2021-09-30 | $128.80M 10-Q · filed 2022-10-27 | $257.90M derived: sum of 2 quarters · filed 2022-10-27 | $367.30M 10-Q · filed 2022-10-27 | $486.50M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | $129.10M 10-Q · filed 2022-07-28 | $238.50M 10-Q · filed 2022-07-28 | $357.70M derived: sum of 3 quarters · filed 2023-02-09 | $445.40M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | $109.40M 10-Q · filed 2022-04-28 | $228.60M derived: sum of 2 quarters · filed 2023-02-09 | $316.30M derived: sum of 3 quarters · filed 2023-02-09 | $396.20M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | $119.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $206.90M derived: sum of 2 quarters · filed 2023-02-09 | $286.80M derived: sum of 3 quarters · filed 2023-02-09 | $359.90M 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | $87.70M 10-Q · filed 2021-10-28 | $167.60M derived: sum of 2 quarters · filed 2021-10-28 | $240.70M 10-Q · filed 2021-10-28 | $319.50M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-06-30 | $79.90M 10-Q · filed 2021-07-29 | $153.00M 10-Q · filed 2021-07-29 | $231.80M derived: sum of 3 quarters · filed 2022-02-14 | $298.50M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-03-31 | $73.10M 10-Q · filed 2021-04-29 | $151.90M derived: sum of 2 quarters · filed 2022-02-14 | $218.60M derived: sum of 3 quarters · filed 2022-02-14 | $287.60M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2019-12-31 | $78.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $145.50M derived: sum of 2 quarters · filed 2022-02-14 | $214.50M derived: sum of 3 quarters · filed 2022-02-14 | $273.50M 10-K · filed 2022-02-14 | ||||
| 2019-09-30 | $66.70M 10-Q · filed 2020-10-27 | $135.70M derived: sum of 2 quarters · filed 2020-10-27 | $194.70M 10-Q · filed 2020-10-27 | $252.30M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $69.00M 10-Q · filed 2020-07-28 | $128.00M 10-Q · filed 2020-07-28 | $185.60M derived: sum of 3 quarters · filed 2021-02-11 | $235.70M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $59.00M 10-Q · filed 2020-04-28 | $116.60M derived: sum of 2 quarters · filed 2021-02-11 | $166.70M derived: sum of 3 quarters · filed 2021-02-11 | $213.90M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $57.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $107.70M derived: sum of 2 quarters · filed 2021-02-11 | $154.90M derived: sum of 3 quarters · filed 2021-02-11 | $199.70M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $50.10M 10-Q · filed 2019-11-06 | $97.30M derived: sum of 2 quarters · filed 2019-11-06 | $142.10M 10-Q · filed 2019-11-06 | $190.80M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $47.20M 10-Q · filed 2019-07-31 | $92.00M 10-Q · filed 2019-07-31 | $140.70M derived: sum of 3 quarters · filed 2020-02-13 | $184.00M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $44.80M 10-Q · filed 2019-05-01 | $93.50M derived: sum of 2 quarters · filed 2020-02-13 | $136.80M derived: sum of 3 quarters · filed 2020-02-13 | $182.10M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $48.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $92.00M derived: sum of 2 quarters · filed 2020-02-13 | $137.30M derived: sum of 3 quarters · filed 2020-02-13 | $185.40M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $43.30M 10-Q · filed 2018-11-06 | $88.60M derived: sum of 2 quarters · filed 2018-11-06 | $136.70M 10-Q · filed 2018-11-06 | $180.40M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-06-30 | $45.30M 10-Q · filed 2018-08-01 | $93.40M 10-Q · filed 2018-08-01 | $137.10M derived: sum of 3 quarters · filed 2019-02-21 | $181.00M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-03-31 | $48.10M 10-Q · filed 2018-05-02 | $91.80M derived: sum of 2 quarters · filed 2019-02-21 | $135.70M derived: sum of 3 quarters · filed 2019-02-21 | $172.00M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2016-12-31 | $43.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $87.60M derived: sum of 2 quarters · filed 2019-02-21 | $123.90M derived: sum of 3 quarters · filed 2019-02-21 | $156.10M 10-K · filed 2019-02-21 | ||||
| 2016-09-30 | $43.90M 10-Q · filed 2017-11-01 | $80.20M derived: sum of 2 quarters · filed 2017-11-01 | $112.40M 10-Q · filed 2017-11-01 | $140.90M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $36.30M 10-Q · filed 2017-08-01 | $68.50M 10-Q · filed 2017-08-01 | $97.00M derived: sum of 3 quarters · filed 2018-02-27 | $161.80M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $32.20M 10-Q · filed 2017-05-02 | $60.70M derived: sum of 2 quarters · filed 2018-02-27 | $125.50M derived: sum of 3 quarters · filed 2018-02-27 | $149.90M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $28.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $93.30M derived: sum of 2 quarters · filed 2018-02-27 | $117.70M derived: sum of 3 quarters · filed 2018-02-27 | $137.50M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $64.80M 10-Q · filed 2016-11-01 | $89.20M derived: sum of 2 quarters · filed 2016-11-01 | $109.00M 10-Q · filed 2016-11-01 | $130.60M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $24.40M 10-Q · filed 2016-08-02 | $44.20M 10-Q · filed 2016-08-02 | $65.80M derived: sum of 3 quarters · filed 2017-02-28 | $84.30M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $19.80M 10-Q · filed 2016-04-27 | $41.40M derived: sum of 2 quarters · filed 2017-02-28 | $59.90M derived: sum of 3 quarters · filed 2017-02-28 | $74.70M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $21.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $40.10M derived: sum of 2 quarters · filed 2017-02-28 | $54.90M derived: sum of 3 quarters · filed 2017-02-28 | $69.40M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $18.50M 10-Q · filed 2015-11-04 | $33.30M derived: sum of 2 quarters · filed 2015-11-04 | $47.80M 10-Q · filed 2015-11-04 | $60.40M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $14.80M 10-Q · filed 2015-08-05 | $29.30M 10-Q · filed 2015-08-05 | $41.90M derived: sum of 3 quarters · filed 2016-02-23 | $53.70M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $14.50M 10-Q · filed 2015-04-29 | $27.10M derived: sum of 2 quarters · filed 2016-02-23 | $38.90M derived: sum of 3 quarters · filed 2016-02-23 | $50.00M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $12.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $24.40M derived: sum of 2 quarters · filed 2016-02-23 | $35.50M derived: sum of 3 quarters · filed 2016-02-23 | $44.80M 10-K · filed 2016-02-23 | ||||
| 2013-09-30 | $11.80M 10-Q · filed 2014-11-06 | $22.90M derived: sum of 2 quarters · filed 2014-11-06 | $32.20M 10-Q · filed 2014-11-06 | $40.80M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $11.10M 10-Q · filed 2014-08-06 | $20.40M 10-Q · filed 2014-08-06 | $29.00M derived: sum of 3 quarters · filed 2015-02-25 | $39.30M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $9.30M 10-Q · filed 2014-05-01 | $17.90M derived: sum of 2 quarters · filed 2015-02-25 | $28.20M derived: sum of 3 quarters · filed 2015-02-25 | $38.20M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $18.90M derived: sum of 2 quarters · filed 2015-02-25 | $28.90M derived: sum of 3 quarters · filed 2015-02-25 | $38.30M 10-K · filed 2015-02-25 | $39.50M 10-K · filed 2013-02-21 | |||
| 2012-09-30 | $10.30M 10-Q · filed 2013-11-06 | $10.58M 10-Q · filed 2012-11-01 | $20.30M derived: sum of 2 quarters · filed 2013-11-06 | $29.70M 10-Q · filed 2013-11-06 | $30.80M 10-Q · filed 2012-11-01 | $37.78M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-06-30 | $10.00M 10-Q · filed 2013-08-07 | $10.50M 10-Q · filed 2012-08-06 | $19.50M 10-Q · filed 2013-08-07 | $20.21M 10-Q · filed 2012-08-06 | $27.48M derived: sum of 3 quarters · filed 2014-02-20 | $35.72M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-03-31 | $9.40M 10-Q · filed 2013-05-01 | $9.71M 10-Q · filed 2012-05-02 | $17.48M derived: sum of 2 quarters · filed 2014-02-20 | $25.72M derived: sum of 3 quarters · filed 2014-02-20 | $32.73M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | $8.09M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $16.32M derived: sum of 2 quarters · filed 2014-02-20 | $23.33M derived: sum of 3 quarters · filed 2014-02-20 | $29.60M 10-K · filed 2014-02-20 | $30.75M 10-K · filed 2012-02-23 | |||
| 2011-09-30 | $8.23M 10-Q · filed 2012-11-01 | $15.25M derived: sum of 2 quarters · filed 2012-11-01 | $21.52M 10-Q · filed 2012-11-01 | $28.39M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $7.02M 10-Q · filed 2012-08-06 | $13.28M 10-Q · filed 2012-08-06 | $20.16M derived: sum of 3 quarters · filed 2013-02-21 | $26.32M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $6.27M 10-Q · filed 2012-05-02 | $13.14M derived: sum of 2 quarters · filed 2013-02-21 | $19.30M derived: sum of 3 quarters · filed 2013-02-21 | $24.73M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $13.04M derived: sum of 2 quarters · filed 2013-02-21 | $18.46M derived: sum of 3 quarters · filed 2013-02-21 | $23.20M 10-K · filed 2013-02-21 | $23.23M 10-K · filed 2012-02-23 | |||
| 2010-09-30 | $6.16M 10-Q · filed 2011-11-02 | $11.59M derived: sum of 2 quarters · filed 2011-11-02 | $16.32M 10-Q · filed 2011-11-02 | |||||
| 2010-06-30 | $5.42M 10-Q · filed 2011-08-03 | $10.16M 10-Q · filed 2011-08-03 | ||||||
| 2009-12-31 | $14.29M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |